Skip to content

Multiple Disseminated Hydatidosis With Rare Locations

Multiple Disseminated Hydatidosis With Rare Locations: Mediastinal, Pancreatic and Pelvic: Case Report

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06109012
Enrollment
1
Registered
2023-10-31
Start date
2021-09-01
Completion date
2021-09-30
Last updated
2023-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Echinococcus Infections

Keywords

echinococcus, serology, multiple locations

Brief summary

Hydatid disease is an anthropozoonosis due to the development of the larval form of Echinococcus granulosus in the human body, which constitutes a 'dead-end' host. It's a common parasitosis in North African countries and constitutes a public health problem in Morocco. The liver and lung are the most affected while the mediastinum, pancreas and pelvis are rarely affected. We report the case of a 40-year-old patient operated 15 years ago for cerebral and cervical hydatid cysts and who was hospitalized for generalized mucocutaneous jaundice. On exploration, we discover the presence of disseminated abdominal hydatidosis with association of 3 rare locations: mediastinal, pancreatic and pelvic. Indirect diagnostic tests were positive: indirect hemagglutination (IHA) and Elisa. The Western blot test also showed the presence of specific bands, thus making it possible to retain the diagnosis of hydatidosis. The hydatid cyst with mediastinal, pancreatic and pelvic location is rare and their association is very exceptional. It is essential to evoke the hydatid origin of any cystic lesion in a patient staying in an endemic area.

Interventions

PROCEDUREduct diversion

the patient benefited from a diversion of the bile ducts complicated by ruptured cysts with anaphylactic shock

Sponsors

Faculty Of Medicine And Pharmacy, Casablanca
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
44 Years to 44 Years
Healthy volunteers
No

Inclusion criteria

* none

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
THE PATIENT DIED due to probably anaphylactic shock1 mounththe patient probably had the rupture of cysts during the surgical procedure with anaphylactic shock as a complication

Countries

Morocco

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026